Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LAMIVUDINE\TENOFOVIR Cause Virologic failure? 71 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 71 reports of Virologic failure have been filed in association with LAMIVUDINE\TENOFOVIR. This represents 32.0% of all adverse event reports for LAMIVUDINE\TENOFOVIR.

71
Reports of Virologic failure with LAMIVUDINE\TENOFOVIR
32.0%
of all LAMIVUDINE\TENOFOVIR reports
0
Deaths
0
Hospitalizations

How Dangerous Is Virologic failure From LAMIVUDINE\TENOFOVIR?

Of the 71 reports.

Is Virologic failure Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LAMIVUDINE\TENOFOVIR. However, 71 reports have been filed with the FAERS database.

What Other Side Effects Does LAMIVUDINE\TENOFOVIR Cause?

Foetal exposure during pregnancy (74) Pathogen resistance (67) Viral mutation identified (67) Congenital umbilical hernia (38) Exposure during pregnancy (34) Abortion spontaneous (23) Maternal exposure during pregnancy (21) Birth mark (16) Premature delivery (9) Congenital naevus (8)

What Other Drugs Cause Virologic failure?

LAMIVUDINE (1,894) EFAVIRENZ (916) TENOFOVIR DISOPROXIL (896) NEVIRAPINE (813) DOLUTEGRAVIR (770) ZIDOVUDINE (741) RITONAVIR (594) RALTEGRAVIR (517) ABACAVIR (490) LOPINAVIR\RITONAVIR (428)

Which LAMIVUDINE\TENOFOVIR Alternatives Have Lower Virologic failure Risk?

LAMIVUDINE\TENOFOVIR vs LAMIVUDINE\TENOFOVIR DISOPROXIL LAMIVUDINE\TENOFOVIR vs LAMIVUDINE\ZIDOVUDINE LAMIVUDINE\TENOFOVIR vs LAMOTRIGINE LAMIVUDINE\TENOFOVIR vs LANADELUMAB LAMIVUDINE\TENOFOVIR vs LANADELUMAB-FLYO

Related Pages

LAMIVUDINE\TENOFOVIR Full Profile All Virologic failure Reports All Drugs Causing Virologic failure LAMIVUDINE\TENOFOVIR Demographics